Amplia takes aim at billion-dollar pancreatic cancer drug market

For everyday punters looking at medical technology companies, the best opportunities often come from identifying a drug that makes other multi-billion-dollar treatments work better. That is the main idea behind Melbourne-based medical company Amplia Therapeutics. While most cancer companies spend billions trying to make stronger, more toxic chemotherapies, Amplia is taking a different path, developing a “shield-breaking” treatment.

Summary by Glance · SMH